Prestige Consumer Healthcare (PBH) Goodwill & Intangibles (2011 - 2026)
Prestige Consumer Healthcare (PBH) posted quarterly Goodwill & Intangibles of $2.9 billion for Q4 2025, up 1.58% year-over-year from $2.8 billion in Q4 2024, and up 2.25% quarter-over-quarter from $2.8 billion in Q3 2025.
Prestige Consumer Healthcare (PBH) Goodwill & Intangibles (2011 - 2026) Analysis & Trends
Prestige Consumer Healthcare's Goodwill & Intangibles history runs 15 years deep, the most recent figure standing at $2.9 billion for Q4 2025.
- In Q4 2025, Goodwill & Intangibles rose 1.58% year-over-year to $2.9 billion; the TTM figure through Dec 2025 stood at $2.9 billion (up 1.58% YoY), while the FY2025 annual figure was $2.8 billion, down 0.9% from the prior year.
- Goodwill & Intangibles for Q4 2025 stood at $2.9 billion, up from $2.8 billion in the prior quarter.
- The five-year high for Goodwill & Intangibles was $3.3 billion in Q4 2021, with the low at $2.8 billion in Q3 2025.
- The 5-year median for Goodwill & Intangibles is $2.9 billion (2023), against an average of $3.0 billion.
- The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles advanced 7.26% in 2022, then retreated 12.4% in 2023.
- Prestige Consumer Healthcare's Goodwill & Intangibles stood at $3.3 billion in 2021, then declined by 1.09% to $3.2 billion in 2022, then retreated by 12.03% to $2.9 billion in 2023, then fell by 0.65% to $2.8 billion in 2024, then gained by 1.58% to $2.9 billion in 2025.
- Business Quant data shows PBH's Goodwill & Intangibles at $2.9 billion in Q4 2025, $2.8 billion in Q3 2025, and $2.8 billion in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.88 Bn |
| Dec 31, 2025 | 2.88 Bn |
| Sep 30, 2025 | 2.82 Bn |
| Jun 30, 2025 | 2.82 Bn |
| Mar 31, 2025 | 2.82 Bn |
| Dec 31, 2024 | 2.84 Bn |
| Sep 30, 2024 | 2.85 Bn |
| Jun 30, 2024 | 2.85 Bn |
| Mar 31, 2024 | 2.85 Bn |
| Dec 31, 2023 | 2.86 Bn |
| Sep 30, 2023 | 2.86 Bn |
| Jun 30, 2023 | 2.86 Bn |
| Mar 31, 2023 | 2.87 Bn |
| Dec 31, 2022 | 3.25 Bn |
| Sep 30, 2022 | 3.25 Bn |
| Jun 30, 2022 | 3.26 Bn |
| Mar 31, 2022 | 3.28 Bn |
| Dec 31, 2021 | 3.28 Bn |
| Sep 30, 2021 | 3.27 Bn |
| Jun 30, 2021 | 3.05 Bn |